WBBM Radio Chicago on MSN2d
FDA approves new treatment for schizophrenia
With Thursday approval from the U.S. Food and Drug Administration for Cobenfy, adults living with schizophrenia will have ...
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb's Cobenfy As First New Class Of Treatment In More Than 3 Decades
Bristol Myers Squibb's Cobenfy has been approved by the FDA as the first new treatment for schizophrenia in decades. The ...
Fox News2d
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...
The American Journal of Managed Care3d
First Schizophrenia Treatment Approved in Decades Targets Cholinergic Receptors
Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of schizophrenia in adults. The FDA approved xanomeline and trospium chloride ...
First Novel Schizophrenia Treatment in Decades Gains FDA Approval
Cobenfy gives patients an alternative to drugs with troublesome side effects.
THE WEEK6d
The 'game-changing' treatment for schizophrenia
About one in 300 people worldwide are affected by schizophrenia, but for decades treatment options have been both static and limited. If the FDA approves the twice-daily pill on Thursday ...
Medical News Today4d
Is lithium an effective treatment for schizophrenia?
However, lithium may also be an effective treatment for schizophrenia. Schizophrenia is a complex mental health condition that causes various symptoms, including hallucinations and delusions.
Psychology Today3d
Coventry Treatment Centers in Pocatello, ID
At half the cost of most private facilities and treatment centers, the Utah Addiction Centers' multi-disorder treatment provides personalized outpatient and residential treatment for depression ...
Becker's Hospital Review2d
FDA approves schizophrenia treatment
The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. The medication, formerly known as KarXT, is the first antipsychotic medication to ...
Yahoo Finance3d
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb's Cobenfy As First New Class Of Treatment In More Than 3 Decades
On Thursday, the FDA approved Bristol Myers Squibb & Co’s (NYSE:BMY) Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. Bristol-Myers added the ...